Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2023	Sep. 30, 2022
Current
Cash and cash equivalents	$ 154,817,164	$ 149,157,861
Incentive and tax receivables	2,165,127	3,192,580
Prepaid expenses and other current assets	827,572	354,162
Total Assets	157,809,863	152,704,603
Current Liabilities
Accounts payable	4,152,846	3,824,777
Accrued liabilities - Note 4	5,985,658	5,944,953
Deferred grant income - Note 3	916,763	443,831
Total Liabilities	11,055,267	10,213,561
Commitments and Contingencies - Note 6
Capital stock Authorized:10,000,000 preferred stock, par value $0.001 per share
Capital stock Authorized:200,000,000 common stock, par value $0.001 per share 81,390,916 common shares (September 30, 2022 - 77,942,815)	81,391	77,944
Additional paid-in capital	429,595,961	387,976,881
Accumulated deficit	(282,922,756)	(245,563,783)
Total Stockholders' Equity	146,754,596	142,491,042
Total Liabilities and Stockholders' Equity	$ 157,809,863	$ 152,704,603